Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Freenome
MedTech
Roche leads Freenome's $254M fundraising for cancer blood tests
Roche has participated in all of Freenome’s past funding rounds and was also solely responsible for a $290 million contribution at the start of 2022.
Andrea Park
Feb 15, 2024 10:27am
Freenome picks up fellow cancer test maker Oncimmune for $16M
May 22, 2023 11:45am
JPM23: What's medtech's place at the conference? CEOs weigh in
Jan 12, 2023 9:45am
JPM23's Medtech Tidbits: Reporting from San Francisco
Jan 11, 2023 11:11am
JPM23: What testmakers like Freenome are taking away from COVID
Jan 10, 2023 10:10am
ESMO: Multi-cancer blood tests show promise but questions remain
Sep 12, 2022 9:43am
